119 related articles for article (PubMed ID: 33431761)
41. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation.
Gulley ML; Pulitzer DR; Eagan PA; Schneider BG
Hum Pathol; 1996 Jan; 27(1):20-7. PubMed ID: 8543306
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Tunisia.
Trimeche M; Ksiâa F; Ziadi S; Mestiri S; Hachana M; Gacem RB; Sriha B; Korbi S
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1001-7. PubMed ID: 19491698
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr virus-associated gastric carcinoma.
Adachi Y; Yoh R; Konishi J; Iso Y; Matsumata T; Kasai T; Hashimoto H
J Clin Gastroenterol; 1996 Oct; 23(3):207-10. PubMed ID: 8899503
[TBL] [Abstract][Full Text] [Related]
44. Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis.
Betge J; Pollheimer MJ; Schlemmer A; Hoefler G; Langner C
Oncol Rep; 2011 Sep; 26(3):567-75. PubMed ID: 21687951
[TBL] [Abstract][Full Text] [Related]
45. An extremely rare case of Epstein-Barr virus-associated gastric carcinoma with differentiation to neuroendocrine carcinoma.
Shimizu A; Takahashi T; Kushima R; Sentani K; Yasui W; Matsuno Y
Pathol Int; 2018 Jan; 68(1):41-46. PubMed ID: 29244230
[TBL] [Abstract][Full Text] [Related]
46. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
47. Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma.
Lee HS; Chang MS; Yang HK; Lee BL; Kim WH
Clin Cancer Res; 2004 Mar; 10(5):1698-705. PubMed ID: 15014022
[TBL] [Abstract][Full Text] [Related]
48. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
[TBL] [Abstract][Full Text] [Related]
49. Epstein-Barr virus-associated gastric adenocarcinomas among Koreans.
Shin WS; Kang MW; Kang JH; Choi MK; Ahn BM; Kim JK; Sun HS; Min KW
Am J Clin Pathol; 1996 Feb; 105(2):174-81. PubMed ID: 8607441
[TBL] [Abstract][Full Text] [Related]
50. Distinct chromosomal aberrations in Epstein-Barr virus-carrying gastric carcinomas tested by comparative genomic hybridization.
zur Hausen A; van Grieken NC; Meijer GA; Hermsen MA; Bloemena E; Meuwissen SG; Baak JP; Meijer CJ; Kuipers EJ; van den Brule AJ
Gastroenterology; 2001 Sep; 121(3):612-8. PubMed ID: 11522745
[TBL] [Abstract][Full Text] [Related]
51. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations.
Wu MS; Shun CT; Wu CC; Hsu TY; Lin MT; Chang MC; Wang HP; Lin JT
Gastroenterology; 2000 Jun; 118(6):1031-8. PubMed ID: 10833477
[TBL] [Abstract][Full Text] [Related]
52. A case of gastric cancer with heterogeneous components of EB virus (+)/TP53 (+) and EB virus (-)/TP53 (-).
Matsuda I; Kan K; Doi S; Motoki Y; Onodera M; Hirota S
Int J Clin Exp Pathol; 2015; 8(9):11766-71. PubMed ID: 26617924
[TBL] [Abstract][Full Text] [Related]
53. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
[TBL] [Abstract][Full Text] [Related]
54. [Virological studies on Epstein-Barr virus-positive gastric carcinoma].
Imai S
Nihon Rinsho; 1997 Feb; 55(2):368-73. PubMed ID: 9046825
[TBL] [Abstract][Full Text] [Related]
55. [Gastric carcinoma is the most frequent Epstein-Barr virus-associated malignancy].
Boysen T; Friborg J
Ugeskr Laeger; 2013 Nov; 175(47A):. PubMed ID: 25353091
[TBL] [Abstract][Full Text] [Related]
56. Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus.
Chong JM; Fukayama M; Hayashi Y; Funata N; Takizawa T; Koike M; Muraoka M; Kikuchi-Yanoshita R; Miyaki M; Mizuno S
Int J Cancer; 1997 Aug; 74(4):450-4. PubMed ID: 9291438
[TBL] [Abstract][Full Text] [Related]
57. Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma.
Borozan I; Zapatka M; Frappier L; Ferretti V
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093097
[TBL] [Abstract][Full Text] [Related]
58. Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the stomach: demonstration of viral genome by in situ hybridization and Southern blot analysis.
Pittaluga S; Loke SL; So KC; Cheung KN; Ma L
Mod Pathol; 1992 Nov; 5(6):661-4. PubMed ID: 1369803
[TBL] [Abstract][Full Text] [Related]
59. Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins.
Ishii H; Gobé G; Kawakubo Y; Sato Y; Ebihara Y
Histopathology; 2001 Feb; 38(2):111-9. PubMed ID: 11207824
[TBL] [Abstract][Full Text] [Related]
60. Correlation Between Infection Status of Epstein-Barr Virus and
Na SJ; Park HL; O JH; Lee SY; Song KY; Kim SH
In Vivo; 2017; 31(4):749-753. PubMed ID: 28652452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
